Transcriptomics

Dataset Information

0

A first-in-class fully modified version of miR-34a with outstanding stability, activity, and anti-tumor efficacy


ABSTRACT: Altered by defects in p53, epigenetic silencing, and genomic loss, the microRNA miR-34a represents one of the most clinically relevant tumor-suppressive microRNAs. Without question, a striking number of patients with cancer would benefit from miR-34a replacement, if poor miR-34a stability, non-specific delivery, and delivery-associated toxicity could be overcome. Here, we highlight a fully modified version of miR-34a (FM-miR-34a) that overcomes these hurdles when conjugated to a synthetically simplistic ligand. FM-miR-34a is orders of magnitude more stable than a partially modified version, without compromising its activity, leading to stronger repression of a greater number of miR-34a targets. FM-miR-34a potently inhibited proliferation and invasion, and induced sustained downregulation of endogenous target genes for >120 hours following in vivo delivery. In vivo targeting was achieved through conjugating FM-miR-34a conjugated to folate (FM-FolamiR-34a), which inhibited tumor growth leading to complete cures in some mice. These results have the ability to revitalize miR-34a as an anti-cancer agent, providing a strong rationale for clinical testing.

ORGANISM(S): Homo sapiens

PROVIDER: GSE237836 | GEO | 2023/09/05

REPOSITORIES: GEO

Dataset's files

Source:
Action DRS
Other
Items per page:
1 - 1 of 1

Similar Datasets

2019-10-14 | PXD015278 | Pride
| PRJNA996912 | ENA
2018-06-26 | GSE99401 | GEO
2015-07-23 | PXD001976 | Pride
2012-08-03 | GSE39730 | GEO
2016-05-24 | MSV000079767 | MassIVE
2020-04-07 | GSE148153 | GEO
2019-02-27 | GSE127211 | GEO
2014-09-22 | GSE40511 | GEO
2019-09-04 | GSE117506 | GEO